Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 11, 2022, titled "CuraTeQ and Orion expand licensing deal for biosimilars distribution in select European markets.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated January 11, 2022, titled "CuraTeQ and Orion expand licensing deal for biosimilars distribution in select European markets.".